跳至主要内容
临床试验/NCT01343160
NCT01343160已完成不适用

Multicenter Study of Removable GORE VIABIL® Biliary Endoprosthesis for Treatment of Benign Biliary Strictures

W.L.Gore & Associates1 个研究点 分布在 1 个国家目标入组 43 人开始时间: 2011年4月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
43
试验地点
1
主要终点
Safe Stent Removal

研究概览

简要总结

The purpose of this study is to generate clinical data to support the use of GORE® VIABIL® Biliary Endoprosthesis in the endoscopic and percutaneous treatment of benign biliary strictures.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Subject is diagnosed with treatable benign biliary stricture which necessitates the need for implantation of a biliary endoprosthesis
  • •Subject is ≥18 years of age
  • •Subject is able to comply with study protocol and follow-up requirements
  • •Written informed consent is obtained using the Investigational Review Board (IRB)/Ethics Committee (EC) approved consent form

排除标准

  • •Subject anatomy ruling out covered self expanding metal stent use (e.g. above hilar region)
  • •Treatment of stricture would require placement of a covered biliary endoprosthesis within a previously placed bare metal stent
  • •The subject has malignant biliary disease
  • •Subject has known pregnancy
  • •Participated in protocol involving investigational drug or device within 90 days prior to entry into this study

研究组 & 干预措施

GORE VIABIL® Biliary Endoprosthesis

Other

Placement of GORE VIABIL® Biliary Endoprosthesis to establish duct patency

干预措施: GORE® VIABIL® Biliary Endoprosthesis (Device)

结局指标

主要结局

Safe Stent Removal

时间窗: Upon Removal

The stent removal is considered safe when the Study Device is removed successfully and without SAEs.

次要结局

未报告次要终点

研究者

发起方
W.L.Gore & Associates
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验